Home › NDC Lookup › RxCUI directory › RxCUI 1862595

Rucaparib 200 MG Oral Tablet [Rubraca] — RxCUI 1862595

RxNorm drug concept · Semantic branded drug
RxCUI 1862595 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1862595
Official nameRucaparib 200 MG Oral Tablet [Rubraca]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRubraca 200 MG Oral Tablet; Rubraca (as rucaparib camisylate) 200 MG Oral Tablet
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rucaparib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Rubraca is prescribed for two specific types of cancer that carry a BRCA gene mutation. For some patients, it's used after ovarian, fallopian tube, or primary peritoneal cancer has...
  • What exactly is Rubraca for — why did my doctor prescribe it?
  • You can take Rubraca with or without food — either way is fine. That said, eating a high-fat meal does increase how much of the drug your body absorbs and delays when it peaks in y...
  • Do I take this with food or on an empty stomach?
📖 Read our full Rucaparib guide →

🕸️ Concept Web — How Rucaparib 200 MG Oral Tablet [Rubraca] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rucaparib 200 MG Oral Tablet [Rubraca] RxCUI 1862595

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rucaparib 1862579
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rubraca 1862585
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rucaparib Oral Tablet 1862583
    • Rucaparib Oral Product 1862581
    • Rucaparib Pill 1862582
    • Rucaparib Oral Tablet [Rubraca] 1862587
    • Rubraca Oral Product 1862588
    • Rubraca Pill 1862589
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rucaparib 200 MG Oral Tablet SCD · 1862593
  • Rucaparib 200 MG SCDC · 1862592
  • Rucaparib Oral Tablet SCDF · 1862583
  • Rucaparib Oral Product SCDG · 1862581
  • Rucaparib Pill SCDG · 1862582

Brand-Name Concepts

  • Rucaparib 200 MG [Rubraca] SBDC · 1862594
  • Rucaparib Oral Tablet [Rubraca] SBDF · 1862587
  • Rubraca Oral Product SBDG · 1862588
  • Rubraca Pill SBDG · 1862589
  • Rubraca BN · 1862585

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1862595 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82154-0783-01 60 TABLET, FILM COATED in 1 BOTTLE (82154-0783-1) Rubraca pharmaand GmbH 2016-12-19
82154-0784-01 60 TABLET, FILM COATED in 1 BOTTLE (82154-0784-1) Rubraca pharmaand GmbH 2017-05-01
82154-0785-01 60 TABLET, FILM COATED in 1 BOTTLE (82154-0785-1) Rubraca pharmaand GmbH 2016-12-19
Observed labelers: pharmaand GmbH (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.